Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02499328
Title Study to Assess Combination of MEDI4736 With Either AZD9150 or AZD5069 in Patients With Metastatic Squamous Cell Carcinoma of Head and Neck
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors AstraZeneca
Indications

oral squamous cell carcinoma

hypopharynx cancer

Advanced Solid Tumor

laryngeal squamous cell carcinoma

oropharynx cancer

head and neck squamous cell carcinoma

Therapies

AZD9150 + Durvalumab

AZD5069 + Durvalumab

Durvalumab

AZD9150

Age Groups: adult
Covered Countries USA | ITA | ESP | DEU | BEL

Facility Status City State Zip Country Details
Research Site Birmingham Alabama 35294 United States Details
Research Site Duarte California 91010 United States Details
Research Site La Jolla California 92093 United States Details
Research Site Los Angeles California 90024 United States Details
Research Site Los Angeles California 90089 United States Details
Research Site Orange California 92868-3298 United States Details
Research Site San Francisco California 94158 United States Details
Research Site Denver Colorado 80218 United States Details
Research Site Plantation Florida 33324 United States Details
Research Site Sarasota Florida 34232 United States Details
Research Site Lafayette Indiana 47905 United States Details
Research Site Boston Massachusetts 02111 United States Details
Research Site Detroit Michigan 48201 United States Details
Research Site Billings Montana 59101 United States Details
Research Site Morristown New Jersey 07960 United States Details
Research Site Cincinnati Ohio 45267-2827 United States Details
Research Site Houston Texas 77030 United States Details
Research Site Fairfax Virginia 22031 United States Details
Research Site Seattle Washington 98109 United States Details
Research Site Antwerpen 2020 Belgium Details
Research Site Brussels 1000 Belgium Details
Research Site Bruxelles 1200 Belgium Details
Research Site Edegem 2650 Belgium Details
Research Site Namur 5000 Belgium Details
Research Site Berlin 12200 Germany Details
Research Site Dresden 1307 Germany Details
Research Site Frankfurt 60488 Germany Details
Research Site Hamburg 20246 Germany Details
Research Site Hannover 30625 Germany Details
Research Site Jena 07743 Germany Details
Research Site Köln 50670 Germany Details
Research Site München 81675 Germany Details
Research Site Milano 20133 Italy Details
Research Site Barcelona 08035 Spain Details
Research Site Hospitalet deLlobregat 08907 Spain Details
Research Site Madrid 28040 Spain Details
Research Site Madrid 28041 Spain Details
Research Site Toledo 45004 Spain Details
Research Site Birmingham B15 2TH United Kingdom Details
Research Site London SE1 9RT United Kingdom Details
Research Site London SW3 6JB United Kingdom Details
Research Site Manchester M20 4BX United Kingdom Details
Research Site Taunton TA1 5DA United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field